Colecalciferol and Salivary hypersecretion - a phase IV clinical study of FDA data

Summary:

Salivary hypersecretion is reported as a side effect among people who take Colecalciferol (cholecalciferol), especially for people who are male, 60+ old, also take Paracetamol, and have Pancreatic carcinoma.

The phase IV clinical study analyzes which people have Salivary hypersecretion when taking Colecalciferol. It is created by eHealthMe based on reports of 21,141 people who have side effects when taking Colecalciferol from the FDA, and is updated regularly.

What is Colecalciferol?

Colecalciferol has active ingredients of cholecalciferol. eHealthMe is studying from 21,263 Colecalciferol users. Check the latest studies of Colecalciferol.

What is Salivary hypersecretion?

Salivary hypersecretion (excess saliva secretion) is found to be associated with 779 drugs and 1,338 conditions by eHealthMe. Check the latest studies of Salivary hypersecretion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

21,141 people reported to have side effects when taking Colecalciferol.
Among them, 28 people (0.13%) have Salivary hypersecretion.

Could Colecalciferol cause Salivary hypersecretion?

Among these 28 people:

What is the gender of people who have Salivary hypersecretion when taking Colecalciferol? *

female: 24 %
male: 76 %

What is the age of people who have Salivary hypersecretion when taking Colecalciferol? *

What are other drugs people take besides Colecalciferol? *

What are other side effects people have besides Salivary hypersecretion? *

Retching (strong involuntary effort to vomit): 8 people, 28.57%
Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 8 people, 28.57%
Arthropathy: 7 people, 25.00%
Fever: 7 people, 25.00%
Hypotension (abnormally low blood pressure): 7 people, 25.00%
Muscle Rigidity (muscle stiffness): 7 people, 25.00%
Fatigue (feeling of tiredness): 6 people, 21.43%
Nausea And Vomiting: 6 people, 21.43%
Weakness: 5 people, 17.86%
Constipation: 5 people, 17.86%

What are the existing conditions these people have? *

Pancreatic Carcinoma (pancreatic cancer): 4 people, 14.29%
Eye Disorder: 3 people, 10.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.71%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 10.71%
Parkinson's Disease: 3 people, 10.71%
Pain: 3 people, 10.71%
Depression: 3 people, 10.71%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 3 people, 10.71%
Thyroid Diseases: 3 people, 10.71%
Hypersensitivity: 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Colecalciferol and have Salivary hypersecretion?

- Check whether Salivary hypersecretion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Colecalciferol:

Colecalciferol (21,263 reports)

Browse all side effects of Colecalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Salivary hypersecretion:

Salivary hypersecretion (779 drugs)

Browse all the conditions that are associated with Salivary hypersecretion:

Salivary hypersecretion (1,338 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cholecalciferol (the active ingredients of Colecalciferol) and Colecalciferol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.